1. Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits

   • Zixi Zhang
   • Cancan Wang
   • Qiming Liu

   Review Article Open access 03 April 2024 Pages: 329 - 342

   

2. Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review

   • Hiroaki Hiraiwa
   • Takahiro Okumura
   • Toyoaki Murohara

   Review Article Open access 04 April 2024 Pages: 343 - 369

   

3. Evaluation of the Lifetime Benefits of Metformin and SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients with Cardiovascular Disease: A Systematic Review and Two-Stage Meta-Analysis

   • Hon Jen Wong
   • Norman H. Lin
   • Ching-Hui Sia

   Systematic Review 08 April 2024 Pages: 371 - 383

   

4. Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis

   • Hasan Mushahid
   • Syeda Ayesha Shah
   • Muhammad Shariq Usman

   Systematic Review 29 April 2024 Pages: 385 - 398

   

5. Digoxin is Not Related to Mortality in Patients with Heart Failure: Results from the SELFIE-TR Registry

   • Rengin Çetin Güvenç
   • Tolga Sinan Güvenç
   • Mehmet Birhan Yılmaz

   Original Research Article 04 April 2024 Pages: 399 - 408

   

6. Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany

   • Alexander Michel
   • Coralie Lecomte
   • Thomas Evers

   Original Research Article 04 April 2024 Pages: 409 - 418

   

7. Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis

   • Ishaque Hameed
   • Syeda Ayesha Shah
   • Mohammad Hamza

   Original Research Article 05 April 2024 Pages: 419 - 431

   

8. Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020

   • Omar S. Alkhezi
   • Leo F. Buckley
   • John Fanikos

   Original Research Article 07 April 2024 Pages: 433 - 444

   

9. Cost–Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China

   • Penglei Chen
   • Yixiang Wang
   • Xuwei Zheng

   Original Research Article 15 April 2024 Pages: 445 - 454

   

10. Comparative Genitourinary Safety of In-class Sodium-Glucose Cotransporter-2 Inhibitors among Patients with Heart Failure with Preserved Ejection Fraction: A Cohort Study

    • Munaza Riaz
    • Jingchuan Guo
    • Haesuk Park

    Original Research Article 30 April 2024 Pages: 455 - 464

11. Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”

    • Hussain Sohail Rangwala
    • Hareer Fatima
    • Burhanuddin Sohail Rangwala

    Letter to the Editor 02 April 2024 Pages: 465 - 466

12. Authors’ Reply to Rangwala et al: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”

    • Ioannis Bellos
    • Smaragdi Marinaki
    • Vassiliki Benetou

    Letter to the Editor 04 April 2024 Pages: 467 - 468